Skyrizi 75 mg

Skyrizi 75 mg is a medicine authorised by Swissmedic under authorisation number 66944. The authorisation holder is AbbVie AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 April 2019 and the authorisation is valid without a time limit. ATC code L04AC18 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 66944
  • ATC L04AC18
  • Biotechnological medicines
Authorisation data
Authorisation number66944
NameSkyrizi 75 mg
Full nameSkyrizi 75 mg, lnjektionslösung in einer Fertigspritze
Authorisation holderAbbVie AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC18
First authorisation18 April 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Skyrizi 75 mg, lnjektionslösung in einer FertigspritzeB18 April 2019
2Skyrizi 150 mg, lnjektionslösung in einer FertigspritzeB07 July 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12Fertigspritze(n)L04AC1807.15.0.B
21Fertigspritze(n)L04AC1807.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Skyrizi 75 mg authorised in Switzerland?

Yes. Skyrizi 75 mg is authorised by Swissmedic under authorisation number 66944, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Skyrizi 75 mg have?

Skyrizi 75 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Skyrizi 75 mg?

The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com